Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Cytokinetics Inc. | 26 | 1 | 3 | 0 | €53.50 | €84.57 | 58.078% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €62.00 | €79.55 | 28.313% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.40 | €47.53 | 73.460% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €16.06 | €28.06 | 74.770% |
| Sutro Biopharma Inc | 18 | 0 | 0 | 0 | €3.84 | €11.05 | 187.719% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | €11.33 | €27.80 | 145.402% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €6.10 | - | - |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €35.60 | €45.98 | 29.157% |
| G1 Therapeutics | 15 | 1 | 2 | 0 | €4.29 | €10.56 | 146.245% |
| Esperion Therapeutis.Inc. | 14 | 0 | 2 | 0 | €2.06 | €8.39 | 306.702% |
| Insmed Inc. | 15 | 1 | 3 | 1 | €23.60 | €42.72 | 80.998% |
| Akero Therapeutics Inc | 13 | 0 | 1 | 0 | €19.44 | €38.62 | 98.679% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €23.57 | €60.55 | 156.911% |
| Geron Corp. | 12 | 0 | 2 | 0 | €3.46 | €4.63 | 33.616% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €25.53 | €35.43 | 38.775% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €15.04 | €24.13 | 60.460% |
| Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | €0.92 | €13.77 | 1403.603% |
| MacroGenics Inc. | 11 | 1 | 3 | 1 | €4.06 | €12.42 | 205.876% |
| Verastem Inc. | 10 | 0 | 1 | 0 | €11.10 | €24.63 | 121.935% |
| Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.58 | €4.58 | 77.679% |
| Evolus Inc | 9 | 0 | 3 | 0 | €11.60 | €20.43 | 76.142% |
| Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €5.22 | €11.05 | 111.470% |
| Chromadex Corp | 11 | 2 | 1 | 0 | €3.16 | €5.58 | 76.449% |
| AnaptysBio Inc | 9 | 1 | 4 | 0 | €22.00 | €45.21 | 105.500% |